The present study discovered a novel protein duo, reticulocalbin-1 and sideroflexin-4, making a breakthrough in understanding the downstream signalling in exacerbation COPD thereby leading to improved clinical management of the disease. Here, RCN1 is linked to chronic obstructive pulmonary disease.